CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $, signifying a +% move from its prior day's close. CRSP Stock Performance ; Previous close, ; Day range, - ; Year range, 37 - 91 ; Market cap, 3,,, ; Primary exchange, NASDAQ. Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with. View the CRSP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Crispr Therapeutics AG. We maintain our positive long-term outlook and $ fair value estimate. We view the stock as very undervalued, currently trading in 5-star territory. Crispr.
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes. Latest news: CRISPR Therapeutics AG · Truist Adjusts Price Target on CRISPR Therapeutics to $ From $, Maintains Buy Rating · Morgan Stanley Cuts Price. CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. The market cap of CRISPR Therapeutics (CRSP) is approximately B. What is CRISPR Therapeutics AG? CRISPR Therapeutics AG is a gene editing company focused on. CRISPR Therapeutics AG ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A ; Latest Dividend, N/A. CRISPR Therapeutics AG is a gene editing company. The Company focuses on developing transformative gene-based medicines for diseases such as hemoglobinopathies. CRISPR Therapeutics AG ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Other Biotechnology & Medical Research ; LONZA GROUP AG · Stock Lonza Group AG. % ; IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc. % ; ALNYLAM. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic. 5 best CRISPR stocks to buy ; CRISPR Therapeutics (NASDAQ:CRSP), $ billion, Beta-thalassemia, sickle cell disease, cancer, diabetes ; Editas Medicine (NASDAQ. CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases.
CRISPR/Cas9 gene-editing platform. When an analyst upgrades a stock, they are signaling that the company's fundamentals are being undervalued by investors. CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases. CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases. According to 19 analysts, the average rating for CRSP stock is "Buy." The month stock price forecast is $, which is an increase of % from the. On Tuesday 09/03/ the closing price of the CRISPR Therapeutics AG share was $ on BTT. Compared to the opening price on Tuesday 09/03/ on BTT of. 1. Crispr Therapeutics (CRSP) · 2. Editas Medicine (EDIT) · 3. Regeneron Pharmaceuticals (REGN) · 4. Cellectis (CLLS) · 5. Beam Therapeutics Inc (BEAM) · 6. Bluebird. Stock Quote & Chart ; Change, % ; Volume, , ; Today's Open, $ ; Previous Close, $ Get the latest Crispr Therapeutics AG (CRSP) real-time quote, historical performance, charts, and other financial information to help you make more informed. 18, (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq:CRSP), a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing technology into.
Below High: NaN% ; Business Description · Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Discover real-time CRISPR Therapeutics AG Common Shares (CRSP) stock prices, quotes, historical data, news, and Insights for informed trading and investment. CRISPR Therapeutics AG is a leading gene editing company focused on developing CRISPR/Cas9-based therapeutics. The company is rapidly leveraging its CRISPR/Cas9. Top 5 CRISPR Companies To Invest In (August ) · The CRISPR Revolution · The CRISPR Mania · Top 5 CRISPR Stocks · finviz dynamic chart for CRSP · finviz dynamic. CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced.
A Crispr analyst says the results of the company's recent study lagged expectations. Another analyst is a buyer on the stock's weakness. CRSP. CMN Markets Newsletter - CRISPR stocks and market news. CMN Markets will bring you the latest news updates from the stock markets. Overview CRISPR companies.